Status:
UNKNOWN
Pregnant Women With Pulmonary Hypertension in China
Lead Sponsor:
First Affiliated Hospital of Chongqing Medical University
Conditions:
Pulmonary Hypertension
Pregnancy, High Risk
Eligibility:
FEMALE
14-50 years
Brief Summary
Little is known about the status of maternal, obstetric and neonatal complications and the potential predictors of developing heart failure (HF) in the mothers with pulmonary hypertension in China. El...
Detailed Description
Pulmonary hypertension is a malignant disease with a high mortality rate, difficult to diagnose at an early stage and has posed a huge economic burden on patients and society. Pregnancy with pulmonary...
Eligibility Criteria
Inclusion
- pregnant women, regardless of age, race
- diagnosed with pulmonary hypertension(PH) before pregnancy or during pregnancy
- diagnosed with PH by right heart catheterization or echocardiography
- diagnostic criteria of right heart catheterization: mean pulmonary artery pressure (mPAP) ≥ 25 mm Hg by right heart catheterization at rest
- diagnostic criteria of echocardiography: pulmonary artery systolic pressure (PASP)≥40 mm Hg
- time: from January 1, 2012 to December 31, 2021
Exclusion
- Patients with isolated exercise-induced PH (mean PAP \<25 mm Hg at rest and \>30 mm Hg at exercise) were excluded.
- pulmonary artery systolic pressure (PASP)\<40 mmHg by echocardiography
- mean pulmonary artery pressure (mPAP) \< 25 mm Hg by right heart catheterization at rest
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2022
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05198206
Start Date
November 1 2021
End Date
May 31 2022
Last Update
January 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the First Affiliated Hospital, Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400016